As Jones Lang Lasalle (JLL) Share Price Declined, Pekin Singer Strauss Asset Management Cut Holding; As Boston Scientific (BSX) Valuation Rose, Pura Vida Investments Has Trimmed Its Holding

February 15, 2018 - By Louis Casey

Pura Vida Investments Llc decreased its stake in Boston Scientific Corp (BSX) by 7.26% based on its latest 2017Q3 regulatory filing with the SEC. Pura Vida Investments Llc sold 30,546 shares as the company’s stock rose 4.02% with the market. The institutional investor held 390,000 shares of the medical and dental instruments company at the end of 2017Q3, valued at $11.38 billion, down from 420,546 at the end of the previous reported quarter. Pura Vida Investments Llc who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $36.72B market cap company. The stock decreased 0.26% or $0.07 during the last trading session, reaching $26.74. About 2.52M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since February 15, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Pekin Singer Strauss Asset Management decreased its stake in Jones Lang Lasalle Inc (JLL) by 5.29% based on its latest 2017Q3 regulatory filing with the SEC. Pekin Singer Strauss Asset Management sold 6,870 shares as the company’s stock declined 3.59% while stock markets rallied. The institutional investor held 122,893 shares of the real estate company at the end of 2017Q3, valued at $15.18 million, down from 129,763 at the end of the previous reported quarter. Pekin Singer Strauss Asset Management who had been investing in Jones Lang Lasalle Inc for a number of months, seems to be less bullish one the $7.16B market cap company. The stock decreased 1.16% or $1.86 during the last trading session, reaching $157.8. About 64,422 shares traded. Jones Lang LaSalle Incorporated (NYSE:JLL) has risen 4.94% since February 15, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Pura Vida Investments Llc, which manages about $223.00M and $199.58B US Long portfolio, upped its stake in Bio Rad Labs Inc (NYSE:BIO) by 5,180 shares to 28,000 shares, valued at $6.22B in 2017Q3, according to the filing. It also increased its holding in Regenxbio Inc by 5,100 shares in the quarter, for a total of 33,920 shares, and has risen its stake in Express Scripts Hldg Co (NASDAQ:ESRX).

Since August 29, 2017, it had 0 buys, and 12 sales for $16.75 million activity. 85,227 shares were sold by Fitzgerald Joseph Michael, worth $2.26M on Wednesday, February 7. On Wednesday, August 30 the insider Nanavaty Maulik sold $1.56 million. Shares for $139,104 were sold by Pierce David A. Pratt Timothy A. also sold $323,435 worth of Boston Scientific Corporation (NYSE:BSX) on Monday, October 2. 347,137 shares were sold by Bose Supratim, worth $10.11M.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 89 analyst reports since July 27, 2015 according to SRatingsIntel. The stock has “Buy” rating by Barclays Capital on Wednesday, June 28. The company was maintained on Wednesday, June 28 by Oppenheimer. The firm earned “Buy” rating on Tuesday, August 1 by Stifel Nicolaus. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by RBC Capital Markets on Thursday, February 1. As per Monday, October 5, the company rating was downgraded by Raymond James. The firm has “Buy” rating by Needham given on Thursday, October 26. The firm has “Buy” rating given on Tuesday, October 31 by SunTrust. The rating was maintained by BMO Capital Markets with “Outperform” on Friday, October 27. Suntrust Robinson initiated Boston Scientific Corporation (NYSE:BSX) on Thursday, February 25 with “Buy” rating. The company was maintained on Thursday, August 31 by Needham.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It is positive, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Northern Trust holds 0.12% or 15.39M shares. Susquehanna Interest Group Llp, a Pennsylvania-based fund reported 22,466 shares. Moreover, Beck Mack & Oliver Limited Liability Com has 0.02% invested in Boston Scientific Corporation (NYSE:BSX) for 24,400 shares. Dekabank Deutsche Girozentrale invested 0.06% in Boston Scientific Corporation (NYSE:BSX). Bb&T Corporation invested in 18,945 shares. Oregon Pub Employees Retirement Fund holds 142,750 shares. Korea Invest Corporation stated it has 2.11M shares or 0.28% of all its holdings. Somerset Limited Liability has 1.28% invested in Boston Scientific Corporation (NYSE:BSX) for 48,200 shares. Duncker Streett invested 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Diligent Investors Ltd Company invested in 10,164 shares or 0.22% of the stock. Nationwide Fund Advisors invested in 0.06% or 541,022 shares. Artemis Inv Mgmt Llp holds 630,119 shares or 0.38% of its portfolio. Renaissance Limited Co invested in 0.07% or 2.01 million shares. Strs Ohio owns 775,907 shares or 0.1% of their US portfolio. Carroll Financial Associate invested 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX).

Since August 15, 2017, it had 0 buys, and 1 sale for $1.00 million activity. The insider PENROSE SHEILA A sold 1,000 shares worth $123,070.

Investors sentiment increased to 1.28 in Q3 2017. Its up 0.16, from 1.12 in 2017Q2. It increased, as 21 investors sold JLL shares while 99 reduced holdings. 49 funds opened positions while 104 raised stakes. 39.55 million shares or 0.29% less from 39.67 million shares in 2017Q2 were reported. Hbk Investments Lp holds 11,401 shares. Ubs Asset Mgmt Americas Incorporated reported 143,749 shares stake. Comerica Financial Bank has 0.03% invested in Jones Lang LaSalle Incorporated (NYSE:JLL). Trillium Asset Management Limited stated it has 0.31% of its portfolio in Jones Lang LaSalle Incorporated (NYSE:JLL). The Texas-based St James Invest Lc has invested 1.95% in Jones Lang LaSalle Incorporated (NYSE:JLL). Motley Fool Wealth Management Limited owns 70,836 shares. Boston Ptnrs reported 232,755 shares or 0.04% of all its holdings. Envestnet Asset Management Inc holds 0% or 3,964 shares. Kbc Gp Nv accumulated 44,912 shares. Ls Limited Company invested in 4,703 shares. Moreover, Sumitomo Mitsui has 0.02% invested in Jones Lang LaSalle Incorporated (NYSE:JLL). High Pointe Capital Limited Liability Corporation reported 1.43% stake. Waterfront Ltd Limited Liability Company has 58,130 shares for 1.02% of their portfolio. Legal & General Grp Inc Public Limited Company invested 0.01% in Jones Lang LaSalle Incorporated (NYSE:JLL). First Republic Invest Mngmt has invested 0% in Jones Lang LaSalle Incorporated (NYSE:JLL).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>